Executives

Dr. Hsing-Mao Art Chu
CEO of T-E Meds &
Vice President of R&D at Immunwork

Dr. Chu received his bachelor’s degree from Chang Gung University, followed by a master’s degree from National Yang Ming University and a Ph.D. from National Taiwan University. After completing his doctoral studies, he conducted postdoctoral research at the Institute of Biological Chemistry, Academia Sinica, and in 2011 joined the laboratory of Distinguished Research Fellow Dr. Tzu-Wen Chang at the Genomics Research Center, where he continued his postdoctoral training with a focus on antibody engineering. His research centered on elucidating the molecular mechanisms underlying the interactions between CεmX and anti-CεmX.

In 2015, Dr. Chu was invited to join Immunwork, where he led the company’s research and development team, leveraging the proprietary T-E technology platform to advance multiple drug development programs. Under his leadership, six drug candidates successfully completed proof-of-concept studies, with two advancing into human clinical trials currently. Dr. Chu is also a co-inventor of more than 90 patents related to Immunwork’s T-E technology platform and its derivative drug candidates. In 2023, he was appointed Chief Executive Officer of T-E Meds, while concurrently serving as Vice President of Research and Development at Immunwork, where he continues to drive the company’s R&D strategy and innovation efforts.

Ms. Ying-Rong Lai
Vice President of Administration & Executive
Assistant to Chairman of T-E Pharma

Ms. Lai obtained her Master degree in Biotechnology Management from National Taiwan University. After graduating from university, she worked in several fields, including cost control and estimation within the company, participating in biddings of multiple industries, spending several years in the high education system and engaged in trade operation and finally entered the financial system. According to her excellent management experiences in several business sectors, she was invited to work as the financial executive.

From 2004 to 2014, she was a key manager of investment at Taishin International Commercial Bank and at Yuanta Commercial Bank and won a number of service excellence awards. In 2014, she was invited by Dr. Tse-Wen Chang to join Immunwork and was responsible for assisting in establishment, administrative and financial affairs of T-E Pharma. She works as the Vice President of Administration & Executive Assistant to Chairman now.